Butler John P.
Insider CIK 1591467 · KERX Director · RLYP Director · AKBA President and CEO, Director · ZYNE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKBA Akebia Therapeutics, Inc. | M Exercise deriv | 2026-08-06 | 2026-08-10 | 350,000 | — | $0 | 525,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise | 2026-08-06 | 2026-08-10 | 350,000 | $0.63 | $220.5K | 3,718,564 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise deriv | 2026-08-06 | 2026-08-10 | 350,000 | — | $0 | 525,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise | 2026-08-06 | 2026-08-10 | 350,000 | $0.63 | $220.5K | 3,718,564 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2026-03-04 | 2026-03-05 | 69,270 | $1.25 | $86.6K | 3,367,064 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2026-02-02 | 2026-02-04 | 46,660 | $1.39 | $64.9K | 3,417,189 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2026-02-02 | 2026-02-04 | 96,065 | $1.39 | $133.5K | 3,321,124 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2026-02-02 | 2026-02-04 | 114,891 | $1.39 | $159.7K | 3,206,233 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2026-02-02 | 2026-02-04 | 83,689 | $1.39 | $116.3K | 3,297,794 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2026-02-02 | 2026-02-04 | 175,250 | $1.41 | $247.1K | 3,381,483 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2026-01-30 | 2026-02-03 | 1,115,000 | — | $0 | 1,115,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2026-01-30 | 2026-02-03 | 743,000 | — | $0 | 3,463,849 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2025-03-03 | 2025-03-04 | 46,409 | $1.83 | $84.9K | 2,557,921 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2025-02-03 | 2025-02-04 | 97,982 | $2.10 | $205.8K | 2,604,330 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2025-02-03 | 2025-02-04 | 46,268 | $2.10 | $97.2K | 2,702,312 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 350,500 | — | $0 | 350,500 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 1,051,400 | — | $0 | 1,051,400 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2025-01-31 | 2025-02-04 | 701,000 | — | $0 | 2,748,580 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2024-02-29 | 2024-03-01 | 46,570 | $1.58 | $73.6K | 2,044,580 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-29 | 37,733 | $1.52 | $57.4K | 2,091,150 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 46,489 | $1.68 | $78.1K | 2,128,883 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 905,200 | — | $0 | 905,200 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2024-01-31 | 2024-02-02 | 603,500 | — | $0 | 2,175,372 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | D To issuer deriv | 2023-10-10 | 2023-10-11 | 71,736 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | D To issuer deriv | 2023-10-10 | 2023-10-11 | 34,663 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 47,824 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 32,941 | — | $0 | 47,824 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2023-06-14 | 2023-06-15 | 115 | $0.35 | $40 | 80,765 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2023-06-13 | 2023-06-15 | 71,736 | — | $0 | 71,736 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-06-13 | 2023-06-15 | 47,824 | — | $0 | 80,880 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-03-01 | 2023-03-03 | 6,370 | $0.88 | $5.6K | 1,568,872 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-03-01 | 2023-03-03 | 47,239 | $0.88 | $41.6K | 1,575,242 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-03-01 | 2023-03-03 | 38,259 | $0.88 | $33.7K | 1,622,481 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2023-02-27 | 2023-03-01 | 38,632 | $0.81 | $31.3K | 1,660,740 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 635,313 | — | $0 | 635,313 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 875,000 | — | $0 | 875,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2023-01-31 | 2023-02-02 | 293,125 | — | $0 | 1,699,372 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2022-06-14 | 2022-06-16 | 34,663 | — | $0 | 34,663 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2022-06-14 | 2022-06-16 | 23,109 | — | $0 | 33,109 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2022-06-14 | 2022-06-16 | 53 | $1.01 | $54 | 33,056 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-03-01 | 2022-03-02 | 24,811 | $2.17 | $53.8K | 1,432,409 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-03-01 | 2022-03-02 | 4,131 | $2.17 | $9.0K | 1,403,247 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-03-01 | 2022-03-02 | 25,031 | $2.17 | $54.3K | 1,407,378 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2022-02-28 | 2022-03-02 | 739,700 | — | $0 | 739,700 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2022-02-28 | 2022-03-02 | 25,053 | $2.15 | $53.9K | 1,164,095 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2022-02-28 | 2022-03-02 | 293,125 | — | $0 | 1,457,220 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2021-08-03 | 2021-08-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2021-08-03 | 2021-08-05 | 5,000 | — | $0 | 10,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2021-04-01 | 2021-04-01 | 4,109 | $3.40 | $14.0K | 1,152,153 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2021-03-16 | 2021-03-18 | 39,520 | — | $0 | 1,156,262 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-02 | 24,674 | $3.40 | $83.9K | 1,116,742 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-02 | 25,316 | $3.40 | $86.1K | 1,141,416 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2021-02-26 | 2021-03-02 | 403,600 | — | $0 | 403,600 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2021-02-26 | 2021-03-02 | 237,400 | — | $0 | 1,166,732 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2020-06-10 | 2020-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2020-02-28 | 2020-03-02 | 403,600 | — | $0 | 403,600 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2020-02-28 | 2020-03-02 | 237,400 | — | $0 | 1,026,632 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2019-11-20 | 2019-11-21 | 50,000 | $3.44 | $172.0K | 887,732 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2019-06-11 | 2019-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise deriv | 2019-06-03 | 2019-06-05 | 287,000 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise | 2019-06-03 | 2019-06-05 | 287,000 | $0.47 | $134.9K | 836,232 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2019-02-28 | 2019-03-05 | 350,000 | — | $0 | 350,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2019-02-28 | 2019-03-05 | 239,500 | — | $0 | 614,382 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | J Other | 2018-12-12 | 2022-02-18 | 1,248 | — | $0 | 375,865 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | F Tax w/h | 2018-12-12 | 2018-12-13 | 135,697 | $8.94 | $1.21M | 374,617 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | P Buy | 2018-08-22 | 2018-08-22 | 5,000 | $6.43 | $32.1K | 5,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise deriv | 2018-07-11 | 2018-07-12 | 100,000 | — | $0 | 287,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise | 2018-07-11 | 2018-07-12 | 100,000 | $0.47 | $47.0K | 510,314 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2018-06-06 | 2018-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2018-04-12 | 2018-04-16 | 35,000 | — | $0 | 35,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-02-28 | 2018-03-02 | 126,300 | — | $0 | 126,300 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2018-02-28 | 2018-03-02 | 88,900 | — | $0 | 408,814 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2017-06-09 | 2017-06-20 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2017-06-09 | 2017-06-20 | 10,000 | — | $0 | 20,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2017-02-21 | 2017-02-23 | 190,000 | $10.14 | $1.93M | 190,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2017-02-21 | 2017-02-23 | 119,500 | — | $0 | 317,780 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise deriv | 2017-01-19 | 2017-01-23 | 20,000 | — | $0 | 387,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise | 2017-01-19 | 2017-01-23 | 20,000 | $0.47 | $9.4K | 373,480 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 4,500 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 4,500 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 3,828 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer deriv | 2016-09-01 | 2016-09-02 | 24,632 | — | $0 | 0 | SEC↗ |
| RLYP Relypsa Inc | D To issuer | 2016-09-01 | 2016-09-02 | 2,250 | $32.00 | $72.0K | 0 | SEC↗ |
| RLYP Relypsa Inc | U Tender | 2016-09-01 | 2016-09-02 | 2,849 | $32.00 | $91.2K | 2,250 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2016-06-21 | 2016-06-23 | 4,500 | — | $0 | 4,500 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2016-06-21 | 2016-06-23 | 2,250 | — | $0 | 5,099 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2016-06-07 | 2016-06-08 | 1,013 | $19.32 | $19.6K | 2,849 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2016-05-26 | 2016-05-27 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2016-05-26 | 2016-05-27 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2016-02-22 | 2016-02-24 | 190,550 | — | $0 | 190,550 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2016-02-22 | 2016-02-24 | 125,500 | — | $0 | 351,173 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise deriv | 2016-01-15 | 2016-01-19 | 25,000 | — | $0 | 407,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise | 2016-01-15 | 2016-01-19 | 25,000 | $0.47 | $11.8K | 225,673 | SEC↗ |
| RLYP Relypsa Inc | S Sale | 2015-06-11 | 2015-06-15 | 1,100 | $34.62 | $38.1K | 3,862 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2015-06-04 | 2015-06-08 | 4,500 | — | $0 | 4,500 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2015-06-04 | 2015-06-08 | 2,250 | — | $0 | 4,962 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise deriv | 2015-05-26 | 2015-05-28 | 50,000 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise | 2015-05-26 | 2015-05-28 | 50,000 | $0.47 | $23.5K | 198,350 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise deriv | 2015-03-09 | 2015-03-11 | 100,000 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise | 2015-03-09 | 2015-03-11 | 100,000 | $0.47 | $47.0K | 148,350 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2015-03-06 | 2015-03-10 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-12-29 | 2014-12-29 | 1,000 | $11.57 | $11.6K | 48,350 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-12-22 | 2014-12-22 | 1,000 | $11.92 | $11.9K | 47,350 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-12-15 | 2014-12-18 | 1,000 | $11.34 | $11.3K | 46,350 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-11-12 | 2014-11-13 | 1,000 | $10.31 | $10.3K | 45,350 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise deriv | 2014-11-11 | 2014-11-13 | 30,500 | — | $0 | 0 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | M Exercise | 2014-11-11 | 2014-11-13 | 30,500 | $0.47 | $14.3K | 44,350 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2014-06-19 | 2014-06-23 | 3,828 | — | $0 | 3,828 | SEC↗ |
| RLYP Relypsa Inc | A Award | 2014-06-19 | 2014-06-23 | 2,712 | — | $0 | 2,712 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2014-05-14 | 2014-08-05 | 46,667 | — | $0 | 46,667 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2014-03-25 | 2014-03-27 | 13,850 | $17.00 | $235.4K | 13,850 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2013-11-14 | 2013-11-18 | 8,247 | — | $0 | 8,247 | SEC↗ |
| RLYP Relypsa Inc | A Award deriv | 2013-11-14 | 2013-11-18 | 16,385 | — | $0 | 16,385 | SEC↗ |